| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Emmaus Life Sciences, Inc. | Director | Common stock, $0.001 par value | 4.77M | $238K | $0.05 | Dec 15, 2023 | Direct |
| Emmaus Life Sciences, Inc. | Director | Common stock, $0.001 par value | 1.27M | $63.5K | $0.05 | Dec 15, 2023 | By Profit Preview International Group Limited |
| Emmaus Life Sciences, Inc. | Director | Options | 100K | $15K | $0.15 | Feb 1, 2024 | Direct |
| Emmaus Life Sciences, Inc. | Director | Convertible Promissory Note dated 2023-01-18 | 0 | $0.50 | Jan 18, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| EMMA | Emmaus Life Sciences, Inc. | Feb 1, 2024 | 1 | $15K | 4 | Feb 5, 2024 | Director |
| EMMA | Emmaus Life Sciences, Inc. | Dec 15, 2023 | 2 | $90.7K | 4 | Dec 19, 2023 | Director |
| EMMA | Emmaus Life Sciences, Inc. | Jan 18, 2023 | 1 | $1M | 4 | Jan 20, 2023 | Director |
| EMMA | Emmaus Life Sciences, Inc. | Jan 12, 2023 | 1 | $450K | 4 | Jan 17, 2023 | Director |